Large Insider Transactions at Rent-A-Center Inc. (RCII), Air Products & Chemicals Inc. (APD), and Pfizer Inc. (PFE)

Page 2 of 2

Moving on to Air Products & Chemicals Inc. (NYSE:APD), the insider trading activity at the company was marked by a noteworthy purchase a couple of days ago. Seifi Gasemi, the Chairman, President and Chief Executive Officer of Air Products & Chemicals, has acquired 20,000 shares at $143.26 each, augmenting his stake to 209,171 shares. The stock of the worldwide supplier of industrial gases and equipment, specialty and intermediate chemicals has grown by slightly over 1% year-to-date, thanks to the recent upsurge in the company’s stock. The stock has gained nearly 13% since the beginning of the previous week and it’s a pity that Seifi Gasemi didn’t boost his stake when it was trading around $129 a share. Air Products & Chemicals has recently reported its financial results for the third quarter of fiscal 2015. The company posted non-GAAG diluted earnings per share (EPS) of $1.65, which yields an increase of 13% on the year. At the same time, Air Products & Chemicals reported a net income of $359 million for the third quarter, up by 14% year-over-year. Within our database, Bill Ackman’s Pershing Square is the largest shareholder of Air Products & Chemicals Inc. (NYSE:APD), holding 20.55 million shares as of the end of March.

Lastly, unlike the previously-discussed companies, Pfizer Inc. (NYSE:PFE) has seen some unusual insider selling activity recently. Loretta V. Cangialosi, the Controller and Senior Vice President of the company, unloaded 24,704 shares through multiple transactions on July 30, remaining with a stake of 174,611 shares. Loretta Cangialosi sold a part of her stake as the stock is currently trading at a new 10-year high, gaining over 15% year-to-date. The multinational pharmaceutical corporation has recently reported the financial results for the second quarter of 2015, posting revenues of $11.85 billion, compared to $12.77 billion reported a year ago. Meanwhile the company posted diluted earnings per share (EPS) of $0.42, down by 7% from the figure reported in the same quarter a year ago. However, Pfizer raised its guidance for the full year, and currently expects adjusted diluted EPS in the range of $2.01 to $2.07, from the previous range of $1.95 to $2.05. The reputable hedge fund Fisher Asset Management, founded and managed by Ken Fisher, is the largest shareholder of Pfizer Inc. (NYSE:PFE) according to our database, owning a stake of 31.81 million shares, as of the end of June.

Disclosure: None

Page 2 of 2